- Home
- MRBK vs SRZN Comparison
MRBK vs SRZN Comparison
Compare MRBK & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRBK | SRZN |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | United States | United States |
| Employees | N/A | 44 |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.5M | 271.6M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRBK | SRZN |
|---|---|---|
| Price | $20.17 | $21.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $20.75 | ★ $38.00 |
| AVG Volume (30 Days) | 149.5K | ★ 169.9K |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.05% | N/A |
| EPS Growth | ★ 30.34 | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $6,316,000.00 | N/A |
| Revenue This Year | $25.40 | $75.35 |
| Revenue Next Year | $8.15 | N/A |
| P/E Ratio | $121.35 | ★ N/A |
| Revenue Growth | ★ 10.13 | N/A |
| 52 Week Low | $13.81 | $8.21 |
| 52 Week High | $21.59 | $35.00 |
Technical Indicators
Market Signals| Indicator | MRBK | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 59.79 | 38.41 |
| Support Level | $18.42 | $20.26 |
| Resistance Level | $20.72 | $24.50 |
| Average True Range (ATR) | 0.65 | 1.75 |
| MACD | 0.02 | -0.23 |
| Stochastic Oscillator | 68.46 | 23.68 |
Price Performance
Historical ComparisonAbout MRBK Meridian Corporation
Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).